| CRC | Colorectal cancer |
| CRLM | Colorectal liver metastases |
| SEER | Surveillance, Epidemiology, and End Results |
| NM’s | Nanomaterials |
| IONs | Iron oxide nanoparticles |
| SPIONs | Superparamagnetic iron oxide nanoparticles |
| QDot | Quantum dots |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| PLGA | Poly-(lactic-co-glycolic acid) |
| 5-FU | 5-Fluorouracil |
| PAMAM | Poly (amidoamine) |
| CNTs | Carbon Nanotubes |
| FDA | U.S. Food and Drug Administration |
| PEG | Polyethylene glycol |
| PLA | Polylactic acid |
| PCL | Polycaprolactone |
| EPR | Enhanced permeability and retention |
| TME | Tumor microenvironment |
| GSH | Reducing substance glutathione |
| DEG | Ethylene glycol oligomers |
| SWCNTs | Single-walled carbon nanotubes |
| PLNPs | Persistent luminescence nanoparticles |